| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Common Stock | Options Exercise | $0 | +2,546 | +8.6% | $0.000000 | 32,321 | 16 Feb 2024 | Direct | F1 |
| transaction | BSX | Common Stock | Tax liability | $74,377 | -1,130 | -3.5% | $65.82 | 31,191 | 16 Feb 2024 | Direct | |
| transaction | BSX | Common Stock | Options Exercise | $0 | +2,833 | +9.1% | $0.000000 | 34,024 | 17 Feb 2024 | Direct | F1 |
| transaction | BSX | Common Stock | Tax liability | $82,736 | -1,257 | -3.7% | $65.82 | 32,767 | 17 Feb 2024 | Direct | |
| transaction | BSX | Common Stock | Options Exercise | $0 | +2,372 | +7.2% | $0.000000 | 35,139 | 18 Feb 2024 | Direct | F2 |
| transaction | BSX | Common Stock | Tax liability | $69,243 | -1,052 | -3% | $65.82 | 34,087 | 18 Feb 2024 | Direct | |
| holding | BSX | Common Stock | 2,542 | 16 Feb 2024 | By 401(k) | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Restricted Stock Units | Options Exercise | $0 | -2,546 | -33% | $0.000000 | 5,092 | 16 Feb 2024 | Common Stock | 2,546 | Direct | F1, F4 | |
| transaction | BSX | Restricted Stock Units | Options Exercise | $0 | -2,833 | -50% | $0.000000 | 2,834 | 17 Feb 2024 | Common Stock | 2,833 | Direct | F1, F5 | |
| transaction | BSX | Deferred Stock Units | Options Exercise | $0 | -2,372 | -100% | $0.000000* | 0 | 18 Feb 2024 | Common Stock | 2,372 | Direct | F2, F6 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| F2 | Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock. |
| F3 | Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan. |
| F4 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant. |
| F5 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant. |
| F6 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant. |